Liaoning Chengda Biotechnology CO., LTD
5 clinical trials · Sponsor
◉ Watch Liaoning Chengda Biotechnology CO., LTD
| Record | Firm | Date |
|---|---|---|
| Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations (NCT07120464) | Liaoning Chengda Biotechnology CO., LTD | 2025-08-15 |
| Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas (NCT06678373) | Liaoning Chengda Biotechnology CO., LTD | 2024-11-14 |
| Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) (NCT06331702) | Liaoning Chengda Biotechnology CO., LTD | 2024-03-02 |
| Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization (NCT06372665) | Liaoning Chengda Biotechnology CO., LTD | 2024-01-01 |
| Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis (NCT06825312) | Liaoning Chengda Biotechnology CO., LTD | 2023-11-11 |
Track Liaoning Chengda Biotechnology CO., LTD automatically
Every clearance here is in the API, with alerts when new ones post.